We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Alogliptin (as benzoate)

Australian Public Assessment Report

AusPAR

AusPAR: Alogliptin (as benzoate) [PDF, 1.1 MB]

AusPAR: Alogliptin (as benzoate) [DOCX, 2.15 MB]

Attachment: Product Information: Alogliptin (as benzoate) [PDF, 276.61 KB]

Attachment: Product Information: Alogliptin (as benzoate) [DOCX, 74.93 KB]

Attachment: Extract from the Clinical Evaluation Report: Alogliptin (as benzoate) [PDF, 2.75 MB]

Attachment: Extract from the Clinical Evaluation Report: Alogliptin (as benzoate) [DOCX, 5.7 MB]

Device/Product Name

Nesina / Vipidia

Active ingredients

Alogliptin (as benzoate)

AusPAR Date

9 January 2014

Published

17 January 2014

Submission Number

PM-2012-01949-3-5

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines